Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease

Neuropathology

Volumn 30, Issue 4, 2010, Pages 408-419

  King, Andrew ^a   Sweeney, Fiona ^b   Bodi, Istvan ^a   Troakes, Claire ^b   Maekawa, Satomi ^a   Al Sarraj, Safa ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

boxing; Dementia; frontotemporal; TDP 43; trauma

Indexed keywords

DNA BINDING PROTEIN; TRANSACTIVE RESPONSE DNA BINDING PROTEIN WITH A MOLECULAR WEIGHT OF 43 KDA; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; BOXING; BRAIN INJURY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DENTATE GYRUS; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; LEWY BODY; LIMBIC SYSTEM; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NEUROPATHOLOGY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MALE; MIDDLE AGED; NEOCORTEX;

EID: 77954149731     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2009.01085.x     Document Type: Article

References (49)

1. Neumann M, Sampathu DM, Kwong LK et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006 314 : 130 133.
2. Arai T, Hasgawa M, Akiyama H et al. TDP-43 is a component of ubiquitin positive tau negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006 351 : 602 611.
3. Mackenzie I, Neumann M, Bigio E et al. Nomenclature for neuropathological subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 2009 117 : 15 18.
4. Higashi S, Iseki E, Yamamato R et al. Concurrence of TDP-43, tau and synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 2007 1184 : 284 294.
5. Josephs K, Whitwell J, Knopman DS et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiological phenotype. Neurol 2008 70 : 1850 1857.
6. Nakashima-Yasuda H, Uryu K, Robinson J et al. Co-morbidity of TDP-43 proteinopathy in Lewy Body related diseases. Acta Neuropathol 2007 114 : 221 229.
7. Uryu K, Nakashima-Yasuda H, Forman M et al. Concomitant TAR-DNA-Binding Protein 43 pathology is present in Alzheimer disease and Corticobasal degeneration but not other tauopathies. J Neuropathol Exp Neurol 2008 67 : 555 564.
8. Freeman S, Spires-Jones T, Hyman B et al. TAR-DNA binding protein 43 in Pick disease. J Neuropathol Exp Neurol 2007 67 : 62 67.
9. Massey L, Lashley T, O'Sullivan S et al. TAR DNA binding protein-43 (TDP-43) proteinopathy in association with progressive supranuclear palsy. Neuropathol Appl Neurobiol 2009 35 (Suppl 29.
10. Hu W, Josephs K, Knopman DS et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer's Disease. Acta Neuropathol 2008 116 : 215 220.
11. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991 82 : 239 259.
12. Alafuzoff I, Parkkinen L, Al-Sarraj S et al. Staging of neurofibrillary pathology in Alzheimer's Disease. A study of the BrainNet consortium. Brain Pathol 2008 18 : 484 496.
13. Amador-Ortiz C, Lin W-G, Ahmed Z et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's Disease. Ann Neurol 2007 61 : 435 445.
14. Lee E, Lee V, Trojanowski J, Neumann M. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol 2008 115 : 305 311.
15. McKeith I, Dickson D, Lowe J et al. Diagnosis and management of dementia with Lewy Bodies. Third report of the DLB consortium. Neurology 2005 65 : 1863 1872.
16. Neumann M, Kwong L, Lee E et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 2009 117 : 137 149.
17. Sampathu D, Neumann M, Kwong L et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006 169 : 1343 1352.
18. Cairns N, Bigio E, Mackenzie I et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol 2007 114 : 5 22.
19. Arai T, Mackenzie I, Hasegawa M et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2009 117 : 125 136.
20. Meldrum B. First Alfred Meyer memorial lecture. Epileptic brain damage: a consequence and cause of seizures. Neuropathol Appl Neurobiol 1997 23 : 185 202.
21. Lin W-L, Dickson D. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 2008 116 : 205 213.
22. Schwab C, Arai T, Hasegawa M, Yu S, McGeer P. Colocalization of transactivation-responsive DNA binding protein 43 and Huntingtin in inclusions of Huntington's Disease. J Neuropathol Exp Neurol 2008 67 : 1159 1165.
23. Rosso S, Landweer E-J, Houterman M et al. Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case-control study. J Neurol Neurosurg Psychiatry 2003 74 : 1574 1576.
24. Corsellis J, Bruton C, Freeman-Browne D. The aftermath of boxing. Psychol Med 1973 3 : 270 303.
25. Corsellis J. Boxing and the brain. Br Med J 1989 298 : 105 109.
26. Roberts G, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatry 1990 53 : 373 378.
27. Guskiewicz K, Marshall S, Bailes J et al. Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery 2005 57 : 719 726.
28. Omalu B, DeKotsky S, Minster R et al. Chronic traumatic encephalopathy in a National Football League player. Neurosurgery 2005 57 : 128 134.
29. Areza-Fegyveres R, Rosemberg S, Castro R et al. Dementia Pugilistica with clinical features of Alzheimer's Disease. Arq Neuropsiquiatr 2007 65 : 830 833.
30. Schmidt M, Zhukareva V, Newell K et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol 2001 101 : 518 524.
31. Tokuda T, Ikeda S, Yanagisawa N et al. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid -protein and tau protein. Acta Neuropathol 1991 82 : 280 285.
32. Hof P, Bouras C, Buée L et al. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol 1992 85 : 23 30.
33. McKee A, Cantu R, Nowinski C et al. Chronic Traumatic Encephalopathy in atheletes; progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009 68 : 709 735.
34. Neumann M, Kwong L, Tuax AC et al. TDP-43 positive white matter pathology in frontotemporal lobar degeneration with ubiquitin positive inclusions. J Neuropathol Exp Neurol 2007 66 : 177 183. (Pubitemid 46673273)
35. Geser F, Winton M, Kwong L et al. Pathological TDP-43 in parkinsonian-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 2008 115 : 133 145. (Pubitemid 350238671)
36. Miklossy J, Steele J, Yu S et al. Enduring involvement of tau, β-amyloid, β-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonian-dementia complex of Guam (ALS/PDC). Acta Neuropathol 2008 116 : 625 637.
37. Gentleman S, Nash M, Sweeting C et al. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 1993 160 : 139 144.
38. Moisse K, Volkening K, Leystra-Lantz C et al. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Brain Res 2009 1249 : 202 211.
39. Pamphlett R, Jew S. TDP-43 inclusions do not protect motor neurons from sporadic ALS. Acta Neuropathol 2009 35 : 222 225.
40. Geddes J, Vowles G, Robinson S, Sutcliffe J. Neurofibrillary tangles but not Alzheimer pathology in a young boxer. Neuropath Appl Neurobiol 1996 22 : 12 16.
41. Jordan B, Relkin N, Ravdin N et al. Apolipoprotein E epsilon 4 associated with chronic traumatic brain injury in boxing. JAMA 1997 278 : 136 140. (Pubitemid 27287671)
42. Poirier J, Davignon J, Bouthillier D et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993 342 (8873 696.
43. Strittmatter W, Saunders A, Schmechel D et al. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993 90 : 1977 1981.
44. Borroni B, Perani D, Archetti S et al. Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration. BMC Neurol 2006 6 : 31.
45. Srinivasan R, Davidson Y, Gibbons L et al. The apolipoprotein E ε4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry 2006 77 : 154 158.
46. Minthon L, Hesse C, Sjogren M et al. The apolipoprotein E epsilon 4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease. Neurosci Lett 1997 226 : 65 67.
47. Beck J, Rohrer J, Campbell T et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008 131 : 706 720.
48. Reimenschider M, Diehl J, Muller U et al. Apolipoprotein E polymorphism in German patients with frontotemporal degeneration. J Neurol Neurosurg Psychiatry 2002 72 : 639 643.
49. Verpillat P, Camuzat A, Hannequin D et al. Apolipoprotein E gene in frontotemporal dementia; an association study and meta-analysis. Eur J Hum Genet 2002 10 : 399 405.